Literature DB >> 9358565

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol).

C Oussoren1, G Storm.   

Abstract

PURPOSE: The aim of the present paper was to assess the effect of inclusion of distearoylphosphatidylethanolamine-poly(ethyleneglycol) (DSPE-PEG) into liposomal bilayers on the lymphatic uptake and lymph node localization of liposomes after subcutaneous administration.
METHODS: [3H]-Cholesteryloleylether labeled liposomes of various composition and sizes were injected s.c. into the dorsal side of the foot of rats. At several time-points after injection, blood levels of liposomes were determined. Lymphatic uptake from the s.c. site of injection and lymph node localization in regional lymph nodes were determined at the end of the 52 h observation period.
RESULTS: The results demonstrate that inclusion of DSPE-PEG into several types of liposomes has only a modest effect on lymphatic uptake. Also lymph node localization is only slightly affected by PEG-mediated steric stabilization.
CONCLUSIONS: Factors other than the presence of a steric barrier are more important in determining lymphatic uptake from the s.c. injection site. The observation that lymph node localization was only slightly affected by PEG-coating strongly suggests that macrophage uptake is not the only important mechanism of lymph node localization of s.c. administered liposomes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358565     DOI: 10.1023/a:1012145410859

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose.

Authors:  C Oussoren; J Zuidema; D J Crommelin; G Storm
Journal:  Biochim Biophys Acta       Date:  1997-09-04

2.  Patterns of lymphatic drainage in the adult laboratory rat.

Authors:  N L Tilney
Journal:  J Anat       Date:  1971-09       Impact factor: 2.610

Review 3.  Fate and behavior of liposomes in vivo: a review of controlling factors.

Authors:  J H Senior
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

4.  Fate of cholesterol-rich liposomes after subcutaneous injection into rats.

Authors:  A Tümer; C Kirby; J Senior; G Gregoriadis
Journal:  Biochim Biophys Acta       Date:  1983-10-04

5.  Use of radiolabeled hexadecyl cholesteryl ether as a liposome marker.

Authors:  G L Pool; M E French; R A Edwards; L Huang; R H Lumb
Journal:  Lipids       Date:  1982-06       Impact factor: 1.880

6.  The use of aqueous space markers to determine the mechanism of interaction between phospholipid vesicles and cells.

Authors:  F C Szoka; K Jacobson; D Papahadjopoulos
Journal:  Biochim Biophys Acta       Date:  1979-03-08

7.  Biological stability of [3H]cholesteryl oleyl ether in cultured fibroblasts and intact rat.

Authors:  Y Stein; G Halperin; O Stein
Journal:  FEBS Lett       Date:  1980-02-25       Impact factor: 4.124

8.  Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes.

Authors:  S M Moghimi; A E Hawley; N M Christy; T Gray; L Illum; S S Davis
Journal:  FEBS Lett       Date:  1994-05-09       Impact factor: 4.124

9.  Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection.

Authors:  T M Allen; C B Hansen; L S Guo
Journal:  Biochim Biophys Acta       Date:  1993-07-25

10.  Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties.

Authors:  V S Trubetskoy; J A Cannillo; A Milshtein; G L Wolf; V P Torchilin
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546

  10 in total
  14 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.

Authors:  Melissa C Hanson; Monica P Crespo; Wuhbet Abraham; Kelly D Moynihan; Gregory L Szeto; Stephanie H Chen; Mariane B Melo; Stefanie Mueller; Darrell J Irvine
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

Review 3.  Design opportunities for actively targeted nanoparticle vaccines.

Authors:  Tarek M Fahmy; Stacey L Demento; Michael J Caplan; Ira Mellman; W Mark Saltzman
Journal:  Nanomedicine (Lond)       Date:  2008-06       Impact factor: 5.307

Review 4.  Active targeted delivery of immune therapeutics to lymph nodes.

Authors:  Baharak Bahmani; Ishaan Vohra; Nazila Kamaly; Reza Abdi
Journal:  Curr Opin Organ Transplant       Date:  2018-02       Impact factor: 2.640

5.  pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model.

Authors:  Yitong J Zhang; Xi Zhan; Liguo Wang; Rodney J Y Ho; Tomikazu Sasaki
Journal:  J Pharm Sci       Date:  2015-03-09       Impact factor: 3.534

6.  Development of systems for targeting the regional lymph nodes for diagnostic imaging: in vivo behaviour of colloidal PEG-coated magnetite nanospheres in the rat following interstitial administration.

Authors:  L Illum; A E Church; M D Butterworth; A Arien; J Whetstone; S S Davis
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

7.  Characterization and in vitro and in vivo testing of CB2-receptor- and NGAL-targeted paramagnetic micelles for molecular MRI of vulnerable atherosclerotic plaque.

Authors:  Bernard C M te Boekhorst; Sandra M Bovens; Juan Rodrigues-Feo; Honorius M H F Sanders; C W A van de Kolk; Antonius I P M de Kroon; Maarten-Jan M Cramer; Pieter A F M Doevendans; Michiel ten Hove; Gerard Pasterkamp; Cees J A van Echteld
Journal:  Mol Imaging Biol       Date:  2010-12       Impact factor: 3.488

8.  Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration.

Authors:  Xi Zhan; Kenny K Tran; Hong Shen
Journal:  Mol Pharm       Date:  2012-11-20       Impact factor: 4.939

9.  Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.

Authors:  Deepa A Rao; M Laird Forrest; Adam W G Alani; Glen S Kwon; Joseph R Robinson
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

10.  PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases.

Authors:  Lisa M Kaminskas; David B Ascher; Victoria M McLeod; Marco J Herold; Caroline P Le; Erica K Sloan; Christopher J H Porter
Journal:  J Control Release       Date:  2013-03-15       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.